Icon (IJF) Stock Forecast & Price Target

3 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

IJF Analyst Ratings

Moderate Buy

9 Buy

4 Hold

1 Sell

Based on 14 analysts giving stock ratings to

Icon

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

IJF Stock 12 Month Forecast

Average Price Target

€155.86

▲(61.15% Upside)

Based on 14 Wall Street analysts offering 12 month price targets for Icon in the last 3 months. The average price target is €155.86 with a high forecast of €180.55 and a low forecast of €126.47. The average price target represents a 61.15% change from the last price of €96.72.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"88":"€88","181":"€181","111.25":"€111.3","134.5":"€134.5","157.75":"€157.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":180.55170315,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€180.55</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":155.86087195000002,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€155.86</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":126.47341525,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€126.47</span>\n  </div></div>","useHTML":true}}],"tickPositions":[88,111.25,134.5,157.75,181],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,158.6,160.28859255,161.97718509999999,163.66577765,165.3543702,167.04296275000002,168.7315553,170.42014785,172.10874040000002,173.79733295,175.4859255,177.17451805000002,178.8631106,{"y":180.55170315,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,158.6,158.38929784230768,158.17859568461537,157.96789352692306,157.75719136923078,157.54648921153847,157.33578705384616,157.12508489615385,156.91438273846154,156.70368058076923,156.49297842307695,156.28227626538464,156.07157410769233,{"y":155.86087195000002,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,158.6,156.12872425,153.6574485,151.18617275,148.714897,146.24362125,143.7723455,141.30106975,138.829794,136.35851825,133.8872425,131.41596675,128.944691,{"y":126.47341525,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":121.95,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.75,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":150.3,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":146.25,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.85,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":152.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":148.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.42,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.42,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.36,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.2,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.6,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€180.55

Average Price Target€155.86

Lowest Price Target€126.47

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ryan Halsted

RBC Capital

€161.36

Buy

66.83%

Upside

Reiterated

07/08/26

RBC Capital Remains a Buy on Icon (ICLR)

Jailendra Singh

Truist Financial

€138.68→€180.55

Buy

86.67%

Upside

Upgraded

06/30/26

Analysts Offer Insights on Healthcare Companies: ProMIS Neurosciences (NASDAQ: PMN) and Icon (NASDAQ: ICLR)

Ann Hynes

Mizuho Securities

€157→€165.72

Buy

71.34%

Upside

Reiterated

06/26/26

Icon price target raised to $190 from $180 at MizuhoIcon price target raised to $190 from $180 at Mizuho

David Windley

Jefferies

€117.75→€168.34

Buy

74.05%

Upside

Reiterated

06/25/26

Jefferies Reaffirms Their Buy Rating on Icon (ICLR)

Eric Coldwell

Robert W. Baird

€146.53→€162.23

Buy

67.74%

Upside

Reiterated

06/25/26

Icon price target raised to $186 from $168 at BairdIcon price target raised to $186 from $168 at Baird

Patrick B Donnelly

Citi

€122.11→€143.92

Hold

48.80%

Upside

Assigned

06/25/26

Icon price target raised to $165 from $140 at CitiIcon price target raised to $165 from $140 at Citi

Casey Woodring

J.P. Morgan

€113.39→€135.2

Hold

39.78%

Upside

Assigned

06/25/26

Icon price target raised to $155 from $130 at JPMorganIcon price target raised to $155 from $130 at JPMorgan

Justin Bowers

Deutsche Bank

€157→€163.98

Buy

69.54%

Upside

Reiterated

06/25/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Icon (NASDAQ: ICLR)

Sean Dodge

BMO Capital

€139.56→€163.11

Buy

68.64%

Upside

Reiterated

06/25/26

Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (NASDAQ: SPRY), Gilead Sciences (NASDAQ: GILD) and Icon (NASDAQ: ICLR)

Charles Rhyee

TD Cowen

€143.05→€171.83

Buy

77.66%

Upside

Assigned

06/24/26

Charles Rhyee Reiterates Buy on Icon, Lifts Price Target to $197 on Earnings Acceleration and Margin Expansion Confidence

Luke Sergott

Barclays

€130.83→€152.64

Hold

57.82%

Upside

Reiterated

06/24/26

Barclays Remains a Hold on Icon (ICLR)

Michael Ryskin

Bank of America Securities

€109.03→€130.83

Sell

35.27%

Upside

Reiterated

06/24/26

Icon Maintained at Sell as Analyst Keeps $125 Price Target Amid Valuation Concerns After In-Line Q1 2026 Results

Max Smock

William Blair

―

Buy

―

Reiterated

06/02/26

Analyst Maintains Buy on ICON as Accounting Overhang Clears and Long‑Term Earnings Growth Outlook Remains Intact

Michael Cherny

Leerink Partners

€109.03→€126.47

Hold

30.76%

Upside

Reiterated

05/28/26

Icon price target raised to $145 from $125 at LeerinkIcon price target raised to $145 from $125 at Leerink

Jamie Clark

Rothschild & Co Redburn

€197.12→€87.22

Hold

-9.82%

Downside

Downgraded

02/17/26

Icon downgraded to Neutral from Buy at Rothschild & Co RedburnIcon downgraded to Neutral from Buy at Rothschild & Co Redburn

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ryan Halsted

RBC Capital

€161.36

Buy

66.83%

Upside

Reiterated

07/08/26

RBC Capital Remains a Buy on Icon (ICLR)

Jailendra Singh

Truist Financial

€138.68→€180.55

Buy

86.67%

Upside

Upgraded

06/30/26

Analysts Offer Insights on Healthcare Companies: ProMIS Neurosciences (NASDAQ: PMN) and Icon (NASDAQ: ICLR)

Ann Hynes

Mizuho Securities

€157→€165.72

Buy

71.34%

Upside

Reiterated

06/26/26

Icon price target raised to $190 from $180 at MizuhoIcon price target raised to $190 from $180 at Mizuho

David Windley

Jefferies

€117.75→€168.34

Buy

74.05%

Upside

Reiterated

06/25/26

Jefferies Reaffirms Their Buy Rating on Icon (ICLR)

Eric Coldwell

Robert W. Baird

€146.53→€162.23

Buy

67.74%

Upside

Reiterated

06/25/26

Icon price target raised to $186 from $168 at BairdIcon price target raised to $186 from $168 at Baird

Patrick B Donnelly

Citi

€122.11→€143.92

Hold

48.80%

Upside

Assigned

06/25/26

Icon price target raised to $165 from $140 at CitiIcon price target raised to $165 from $140 at Citi

Casey Woodring

J.P. Morgan

€113.39→€135.2

Hold

39.78%

Upside

Assigned

06/25/26

Icon price target raised to $155 from $130 at JPMorganIcon price target raised to $155 from $130 at JPMorgan

Justin Bowers

Deutsche Bank

€157→€163.98

Buy

69.54%

Upside

Reiterated

06/25/26

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA) and Icon (NASDAQ: ICLR)

Sean Dodge

BMO Capital

€139.56→€163.11

Buy

68.64%

Upside

Reiterated

06/25/26

Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (NASDAQ: SPRY), Gilead Sciences (NASDAQ: GILD) and Icon (NASDAQ: ICLR)

Charles Rhyee

TD Cowen

€143.05→€171.83

Buy

77.66%

Upside

Assigned

06/24/26

Charles Rhyee Reiterates Buy on Icon, Lifts Price Target to $197 on Earnings Acceleration and Margin Expansion Confidence

Luke Sergott

Barclays

€130.83→€152.64

Hold

57.82%

Upside

Reiterated

06/24/26

Barclays Remains a Hold on Icon (ICLR)

Michael Ryskin

Bank of America Securities

€109.03→€130.83

Sell

35.27%

Upside

Reiterated

06/24/26

Icon Maintained at Sell as Analyst Keeps $125 Price Target Amid Valuation Concerns After In-Line Q1 2026 Results

Max Smock

William Blair

―

Buy

―

Reiterated

06/02/26

Analyst Maintains Buy on ICON as Accounting Overhang Clears and Long‑Term Earnings Growth Outlook Remains Intact

Michael Cherny

Leerink Partners

€109.03→€126.47

Hold

30.76%

Upside

Reiterated

05/28/26

Icon price target raised to $145 from $125 at LeerinkIcon price target raised to $145 from $125 at Leerink

Jamie Clark

Rothschild & Co Redburn

€197.12→€87.22

Hold

-9.82%

Downside

Downgraded

02/17/26

Icon downgraded to Neutral from Buy at Rothschild & Co RedburnIcon downgraded to Neutral from Buy at Rothschild & Co Redburn

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ASNDAscendis Pharma

CRBPCorbus Pharmaceuticals

ACHVAchieve Life Sciences

CELCCelcuity

GKOSGlaukos

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Icon

3 Months

David WindleyJefferies

Success Rate

27/43 ratings generated profit

Average Return

+2.98%

Copying David Windley's trades and holding each position for 3 Months would result in 62.79% of your transactions generating a profit, with an average return of +2.98% per trade.

1 Year

David WindleyJefferies

Success Rate

26/43 ratings generated profit

Average Return

+3.96%

Copying David Windley's trades and holding each position for 1 Year would result in 60.47% of your transactions generating a profit, with an average return of +3.96% per trade.

2 Years

David WindleyJefferies

Success Rate

26/43 ratings generated profit

Average Return

+10.25%

Copying David Windley's trades and holding each position for 2 Years would result in 60.47% of your transactions generating a profit, with an average return of +10.25% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IJF Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, IJF has received 17 Buy Ratings, 14 Hold Ratings, and 3 Sell Ratings. IJF average Analyst price target in the past 3 months is 155.86.

Each month's total comprises the sum of three months' worth of ratings.

IJF Financial Forecast

IJF Earnings Forecast

Next quarter’s earnings estimate for IJF is €2.23 with a range of €2.13 to €2.30. The previous quarter’s EPS was €2.19. IJF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year IJF has Performed in-line its overall industry.

IJF Sales Forecast

Next quarter’s sales forecast for IJF is €1.76B with a range of €1.73B to €1.79B. The previous quarter’s sales results were €1.78B. IJF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year IJF has Performed in-line its overall industry.

IJF Stock Forecast FAQ

What is DE:IJF’s average 12-month price target, according to analysts?

Based on analyst ratings, Icon Plc’s 12-month average price target is 155.86.

What is DE:IJF’s upside potential, based on the analysts’ average price target?

Icon Plc has 61.15% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Icon Plc a Buy, Sell or Hold?

Icon Plc has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 4 hold ratings and 1 sell ratings.

What is Icon Plc’s share price target?

The average share price target for Icon Plc is 155.86. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €180.55 ,and the lowest forecast is €126.47. The average share price target represents 61.15% Increase from the current price of €96.72.

What do analysts say about Icon Plc?

Icon Plc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of Icon Plc?

To buy shares of DE:IJF, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Icon (IJF) Stock Forecast & Price Target

IJF Analyst Ratings

IJF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Icon

IJF Analyst Recommendation Trends

IJF Financial Forecast

IJF Earnings Forecast

IJF Sales Forecast

IJF Stock Forecast FAQ

Detailed List of Analyst Forecasts